Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Population Genetics Launches Populus Award 2012

Published: Tuesday, October 16, 2012
Last Updated: Tuesday, October 16, 2012
Bookmark and Share
Award offers financial and expert practical support for the completion of a multi-sample gene sequencing project using Population Genetics’ proprietary technologies.

Population Genetics Technologies Ltd. has launched the Populus Award 2012. Inviting abstracts from researchers undertaking a range of population genetics studies, the award will provide the successful applicant with funding and practical support for their sequencing study, as well as access to the extensive expertise and proprietary technologies provided by Population Genetics.

These technologies have the power to increase the efficiency and accuracy of next generation sequencing (NGS) studies, allowing researchers to reliably link genotypic variation with phenotype.

Other applicants will also have the chance to benefit from the award, receiving collaborative advice and input from the experts at Population Genetics to help them to further advance their research projects.

Dr. Frank Massam, Chief Commercial Officer, Population Genetics, commented: “The Populus Award 2012 provides an ideal opportunity for a research group with limited funds or experience to gain access to the latest technological and practical expertise in the field. Using our proprietary approaches and funding support, we will enable them to accurately sequence either genomic regions of interest or indeed, whole genes in large populations of samples, providing the next leap in sequencing analysis.”

For the successful applicant, Population Genetics will use its established approach to sequence their samples using the NGS platform of their choice.

An innovative molecular tagging system enables the accurate sequencing of either multiple non-contiguous or long, contiguous regions from many thousands of samples, in a single experiment.

This allows researchers to confidently identify genetic variants attributed to a specific phenotype. Such high quality data is significantly valuable in areas such as human healthcare, as it mediates the rapid discovery of gene variants characteristic of a particular disorder or a specific drug response, facilitating the development of informed, personalized treatment strategies.

Applications must be submitted online by the 30th of November 2012. The successful applicant will be announced in January 2013.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Population Genetics Launches Funding Award for Novel Population Sequencing Studies
The Populus Award 2012 offers financial and expert practical support for the completion of a multi-sample gene sequencing project.
Monday, October 15, 2012
Population Genetics Collaborates with Cambridge University to Unravel the Genetic Causes of Asperger Syndrome
Joint study aims to identify sequence variants in two genes, both of which have been previously associated with Asperger Syndrome.
Monday, July 09, 2012
Population Genetics Collaborate with University of Oxford
The company has signed a collaboration agreement with the University of Oxford to provide university researchers with genetic analyses for hypothesis validation and biomarker discovery.
Monday, June 18, 2012
EU Funds Population Genetics in Leukaemia Study Consortium
Company will study the resulting biobank by using GenomePooling™ workflows.
Tuesday, May 29, 2012
Dr Alan Schafer to head Population Genetics as CEO
Schafer brings deep experience in research, “big pharma” management and building new businesses.
Thursday, May 03, 2012
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!